Possible involvement of advanced glycation end products in carry-over benefits of atorvastatin in ASCOT-BPLA.
Sho-ichi
S
Yamagishi
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000188:drug therapy*; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D011758:Pyrroles / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D017127:Glycation End Products, Advanced; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin